Clinical Outcomes of Patients With Resectable Non-Small Cell Lung Cancer Receiving Neoadjuvant Nivolumab Plus Chemotherapy in France
Clinical trial NCT06735781 · COMPLETED
Trial details
- NCT number
- NCT06735781
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2024-09-05
- Primary completion
- 2024-10-01
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.